Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
Open Access
- 1 January 2016
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (38), 8447-8458
- https://doi.org/10.3748/wjg.v22.i38.8447
Abstract
The association of hepatitis C virus (HCV) and B-cell non-Hodgkin lymphomas (NHL) has been highlighted by several epidemiological and biological insights; however the most convincing evidence is represented by interventional studies demonstrating the capability of antiviral treatment (AT) with interferon (IFN) with or without ribavirin to induce the regression of indolent lymphomas, especially of marginal-zone origin. In the largest published retrospective study (100 patients) the overall response rate (ORR) after first-line IFN-based AT was 77% (44% complete responses) and responses were sustainable (median duration of response 33 mo). These results were confirmed by a recent meta-analysis on 254 patients, demonstrating an ORR of 73%. Moreover this analysis confirmed the highly significant correlation between the achievement of viral eradication sustained virological response (SVR) and hematological responses. Two large prospective studies demonstrated that AT is associated with improved survival and argue in favor of current guidelines’ recommendation of AT as preferential first-line option in asymptomatic patients with HCV-associated indolent NHL. The recently approved direct-acting antiviral agents (DAAs) revolutionized the treatment of HCV infection, leading to SVR approaching 100% in all genotypes. Very preliminary data of IFN-free DAAs therapy in indolent HCV-positive NHL seem to confirm their activity in inducing lymphoma regression.Keywords
This publication has 67 references indexed in Scilit:
- The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentThe Journal of Experimental Medicine, 2012
- Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphomaWorld Journal of Hepatology, 2011
- Stereotyped patterns of B-cell receptor in splenic marginal zone lymphomaHaematologica, 2010
- Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALTAnnals of Oncology, 2009
- Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infectionInternational Journal of Cancer, 2009
- A multicenter retrospective clinical study of CD5/CD10‐negative chronic B cell leukemiasAmerican Journal of Hematology, 2008
- Primary nodal marginal zone B‐cell lymphoma: clinical features and prognostic assessment of a rare diseaseBritish Journal of Haematology, 2006
- Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic StudiesCancer Epidemiology, Biomarkers & Prevention, 2006
- Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALTAnnals of Oncology, 2006
- Clinical Features and Outcome in HCV-positive Aggressive Non-Hodgkin's LymphomaLeukemia & Lymphoma, 2003